CTNNA3 genetic polymorphism may be a new genetic signal of type 2 diabetes in the Chinese Han population: a case control study

被引:4
|
作者
Zhang, Yunjun [1 ]
Zhou, Xiaoman [1 ]
Dai, Wanjuan [2 ]
Sun, Juan [1 ]
Lin, Mei [1 ]
Zhang, Yutian [1 ]
Ding, Yipeng [1 ]
机构
[1] Hainan Gen Hosp, Dept Gen Practice, Xiuhua Rd 19, Haikou 570311, Hainan, Peoples R China
[2] Hainan Gen Hosp, Ctr Hlth, Haikou 570311, Hainan, Peoples R China
关键词
Type; 2; diabetes; Case-control study; CTNNA3; Single nucleotide polymorphisms; GENOME-WIDE ASSOCIATION; INCREASED RISK; SUSCEPTIBILITY; VARIANTS; MELLITUS; GENDER; LOCI;
D O I
10.1186/s12920-021-01105-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Type 2 Diabetes (T2D) is the result of a combination of genes and environment. The identified genetic loci can only explain part of T2D risk. Our study is aimed to explore the association between CTNNA3 single nucleotide polymorphisms (SNPs) and T2D risk. Methods We conducted a 'case-control' study among 1002 Chinese Han participants. Four candidate SNPs of CTNNA3 were selected (rs10822745 C/T, rs7920624 A/T, rs2441727 A/G, rs7914287 A/G), and logistic regression analysis was used to evaluate the association between candidate SNPs and T2D risk. We used single factor analysis of variance to analyze the differences of clinical characteristics among different genotypes. In this study, haplotype analysis was conducted by plink1.07 and Haploview software and linkage disequilibrium (LD) was calculated. The interaction of candidate SNPs in T2D risk was evaluated by multi-factor dimensionality reduction (MDR). Finally, we conducted a false-positive report probability (FPRP) analysis to detect whether the significant findings were just chance or noteworthy observations. Results The results showed that CTNNA3-rs7914287 was a risk factor for T2D ('T': OR = 1.33, p = 0.003; 'TT': OR = 2.21, p = 0.001; 'TT' (recessive): OR = 2.09, p = 0.001; Log-additive: OR = 1.34, p = 0.003). The results of subgroup analysis showed that rs7914287 was significantly associated with the increased risk of T2D among participants who were older than 60 years, males, smoking, drinking, or BMI > 24. We also found that rs2441727 was associated with reducing the T2D risk among participants who were older than 60 years, smoking, or drinking. In addition, rs7914287 was associated with T2D patients with no retinal degeneration; rs10822745 and rs7920624 were associated with the course of T2D patients. High density lipoprotein levels had significant differences under different genotypes of rs10822745. Under the different genotypes of rs7914287, the levels of aspartate aminotransferase, alanine aminotransferase and gamma-glutamyltransferase were also significantly different. Conclusion We found that CTNNA3 genetic polymorphisms can be used as a new genetic signal of T2D risk in Chinese Han population. Especially, CTNNA3-rs7914287 showed an outstanding and significant association with T2D risk in both overall analysis and subgroup analysis.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] CTNNA3 genetic polymorphism may be a new genetic signal of type 2 diabetes in the Chinese Han population: a case control study
    Yunjun Zhang
    Xiaoman Zhou
    Wanjuan Dai
    Juan Sun
    Mei Lin
    Yutian Zhang
    Yipeng Ding
    BMC Medical Genomics, 14
  • [2] Genetic variants in ADIPOQ gene and the risk of type 2 diabetes: a case-control study of Chinese Han population
    Du, Wencong
    Li, Qian
    Lu, Ying
    Yu, Xiaofang
    Ye, Xinhua
    Gao, Yanqin
    Ma, Jianhua
    Cheng, Jinluo
    Cao, Yuanyuan
    Du, Juan
    Shi, Hui
    Zhou, Ling
    ENDOCRINE, 2011, 40 (03) : 413 - 422
  • [3] Genetic variants associated with lean and obese type 2 diabetes in a Han Chinese population A case-control study
    Kong, Xiaomu
    Xing, Xiaoyan
    Hong, Jing
    Zhang, Xuelian
    Yang, Wenying
    MEDICINE, 2016, 95 (23)
  • [4] Metabolic and Genetic Markers Improve Prediction of Incident Type 2 Diabetes: A Nested Case-Control Study in Chinese
    Liu, Jia
    Wang, Lu
    Qian, Yun
    Shen, Qian
    Yang, Man
    Dong, Yunqiu
    Chen, Hai
    Yang, Zhijie
    Liu, Yaqi
    Cui, Xuan
    Ma, Hongxia
    Jin, Guangfu
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (11) : 3120 - 3127
  • [5] Association between STAT4 gene polymorphism and type 2 diabetes risk in Chinese Han population
    Cui, Jiaqi
    Tong, Rui
    Xu, Jing
    Tian, Yanni
    Pan, Juan
    Wang, Ning
    Chen, Huan
    Peng, Yanqi
    Fei, Sijia
    Ling, Wang
    Guo, Chaoying
    Yao, Juanchuan
    Cui, Wei
    BMC MEDICAL GENOMICS, 2021, 14 (01)
  • [6] Association study of genetic variants in eight genes/loci with type 2 diabetes in a Han Chinese population
    Lin, Ying
    Li, Pengqiu
    Cai, Li
    Zhang, Ben
    Tang, Xin
    Zhang, Xuejun
    Li, Ying
    Xian, Yang
    Yang, Yang
    Wang, Li
    Lu, Fang
    Liu, Xiaoqi
    Rao, Shaoqin
    Chen, Ming
    Ma, Shi
    Shi, Yi
    Bao, Mingjing
    Wu, Jichuan
    Yang, Yan
    Yang, Jiyun
    Yang, Zhenglin
    BMC MEDICAL GENETICS, 2010, 11
  • [7] Evaluation of the Association Between the ADRA2A Genetic Polymorphisms and Type 2 Diabetes in a Chinese Han Population
    Li, Tianjie
    Zhu, Xilin
    Wu, Xiaopan
    Li, Jingyun
    Pan, Liping
    Li, Pengtao
    Xin, Zhenhui
    Gu, Harvest F.
    Liu, Ying
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (12) : 1424 - 1427
  • [8] Combined effects of 17 common genetic variants on type 2 diabetes risk in a Han Chinese population
    Qi, Q.
    Li, H.
    Wu, Y.
    Liu, C.
    Wu, H.
    Yu, Z.
    Qi, L.
    Hu, F. B.
    Loos, R. J. F.
    Lin, X.
    DIABETOLOGIA, 2010, 53 (10) : 2163 - 2166
  • [9] Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population
    Zhu, Shuying
    Liu, Yang
    Wang, Xin
    Wu, Xiaopan
    Zhu, Xilin
    Li, Jingyun
    Ma, Juan
    Gu, Harvest F.
    Liu, Ying
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 86 (03) : 168 - 172
  • [10] Genetic variants for type 2 diabetes and new-onset cancer in Chinese with type 2 diabetes
    Ma, R. C. W.
    So, W. Y.
    Tam, C. H. T.
    Luk, A. O.
    Ho, J. S. K.
    Wang, Y.
    Lam, V. K.
    Lee, H. M.
    Kong, A. P.
    Tong, P. C.
    Xu, G.
    Chow, C. C.
    Ng, M. C.
    Yang, X. L.
    Chan, J. C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (02) : 328 - 337